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pressure difference belween the left .entricle ana the annk root or 
a peripheral artery 64. Klues et al. (I) measured the diticrencc 
between the left ventricular apex and oulflow tact. They did not 
control the position of the catheter during exercise. tf the p&don of 
the proximal crtheter OT Ihe proximal hole was altered dunng 
exercise, enrrapment couid have occurred and abolished the prel- 
<“re gradient. 
Thus, in hypertmphic cardiomyopathy. published repons and 
our personal observations favor the Fxl that mwmu~ and left 
ventricular pressure gradient most often increase during cwcisc. 
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The authors also criticize a possible bias in patient sekcti(H1 due 
to the predominance of patients with the nonobwxtive disease in 
our series. This is in contradiction to the ynerally accepted d&i- 
tion of obstm&r kypertrophic cardiamyopathy. All included pa- 
Gents had obstruction, as sign&ant gradients (275 mm Hg) were 
obtained tithe: at resl or during standard provocative maneuvers. 
Nonobstructive hypenrophic cardiomyopathy is defined as rm pa.- 
dicnl af rat or 40 mm Hg during “ny possible provocative 
maI?:-we: !U. 
We are ako welt aware of possible misinterpretations caused by 
catheter entraptux~r or displacement during exereire. To avoid 
these problems. great care was taken to place the catheler in a stable 
pozmon in the left vennicular apex and outflow tract or ascending 
aorta. The correct catheter positioo was checked repeatedly as well 
as the morphology of pressure tracings so that errors could be 
excluded. 
The comments of Millaire el al. concerning the behavior of left 
ventricular outflow tract obslruction in hypertmphic cardiomyopa- 
thy are of course in agreement with most previously published 
descriptions and probably the vast majority of personal clinical 
experiences. To underscore the correctness of their assumption. 
that the gradient will increaSe during exercise. rbe authors pwled 
the results of several invasive and noninvarive studies and per- 
formed a statistical test with significant results. This method, 
however, is highly questionable and includes a number of errors that 
have been ignored by the auLors. 
First, the majority of the invasive studies were not designed 
primarily to measure gradients during exercise but to study the 
effect of pharmacologic interventions on outflow tract obstruction. 
Another, more limiting factor is rhal the noniavasive rludies 
utilidng M+made and Doppler echc+xddiography have considerable 
technical problems in ablaining reliable measurements duria: exr- 
cisc; therefore, only p&exercise measurements are usually ob- 
Subgroup Analyses in the I.S.A.M. Trial 
Voth et al. (1) make a very interestingobservation in theirarticleon 
kn venaicular fitnc~ion in patients who rxeived intravenous strep 
tokinase for acute myocardial infarction during fhe 1st 6 h of 
~ympmms. They coaclude that both regional and dabal left venttic- 
ular function improve significantly in patients with anterior myocar- 
dial infarction and the impmvement is preserved for 3 years as 
compared with findings in the placebo group. However. they failed 
to show similar benefits in patients with inferior wall myocardial 
infarction. In my opinion, the entire analysis n&s to be put into 
proper peqeclive before lhese conclusions can he accepted. 
The intravenous Streptokinase in Acute Myocardial Infarction 
(1.S.A.tM.I trial (2) was a pmspective, placetxxontmlled, double- 
blind multicenter trial that was not designed to study the effects of subgroup analysis, careful statistical analysis may be helpful. For 
intravenous streptokinase on long-term left ventricular foncrion. example, one could apply a rule derived from Bonferroni inequality 
The primary study end point was a comparison of mortality 21 days (8) while assessing the importance of p value. If the number of 
atIer infarction in streptokinasc- and placebo-treated patients. Con- subgroups to be examined can be specified a priori, the guideline for 
sidering the amount of data available at their disposal, the authors 
were tempted to perform a numberofsubgroup analyses to highlight 
the pmnounced effect on early and late left ventricular ejection 
fraction in patients with anterior wall myocardial intaretion (1). 
Under such circumstances, two impmtant questions need to be 
answered: I) are authors justified in carrying out such retrospective 
subgmup analyses, and 2) what are the major limitations of such aa 
exercise? Lee et al. (31 simulated a randomized clinical irial using 
data fmm 1,073 patients from ihe Duke University data bank to 
illustrate the fallacies arising from retrospective subgroup analysis. 
They emphasize the need for clinical judgment and modem statisti- 
cal methods in assessing therapeutic claims in studies of complex 
diseases like coronary artery disease. 
aCceptit@ sigttjscance in a particular comparison is whether ihe p 
value is <0.05/k, where. k is the number of subgroups to be analyzed 
(9). 
Baseline characteristics have been compared by the authors 
using uaivariate statistics. When it is well koown lbat interaciionr of 
baseline variables play an important role in deciding the Ieft veo- 
tricular ejection fraction, is it not necessary to at least use a 
multivariate model? Ideally, hypothesis rests are not a valid way of 
assessing similarity between groups; such an assessment should be 
based on consideration of the prognostic s:rengrh of the vtiables 
and the magnitudeof imbalance (IO,1 I).Yherefore. it is possible that 
the positive result in patients with anterior wall myocardii iofarc- 
tion may have been related to improperly matched baseline vati- 
able% 
tinciaork a&&n1 results only as a’matter of chance, as-the 
Because alot oftime, money and energy go inlocwducting large 
rrials of the nature of I.S.A.M., it is natu~??! that one would be 
tempted to analyze different subgmups. However. the conclusions 
authors of ISIS-2 (S) have shown conclusively. Even when treat- 
drawn from a study that was not designed for that p”lpqse can 
merely generate hypotheses that need to be proved by another 
meats truly have similar e&cts in differeot subgmupr. the play of 
pmspective, randomized and ~n!mlledirial(4). Moreover, multiple 
subarow analvses. such as those in the oresent study. are likelv to 
chance may well exaggerate, dilute or occasionally reverse the 
results in a particular subgroup (6). During the cotttx of a long-term 
study, changes in the characteristics of patien!s who have compa- 
rable L2seline variables at the star( of the trial may render the 
interpretation of subgroup effects problematic (6). Such a probahil- 
ily cannot he excluded in the present study, which lasted 3 years. 
Although 64 pafients wex assigned to the streplokinase group and 
60 10 the placebo group, 25% nf pat&nts from the strepltinase 
To define the extent of coronary artery disease as single-. 
double- or triple-vessel disease appears to be an ovenimplied way 
functional status of the patient. Unfortutta~ely, the aut&rs have not 
of comparing z~pecially when we are aaalyzing left ventricular 
function. A scoring system based on myccardium supplied by that 
presented the comparison of this variable. When comparing the 
anery would have been a more precise way of comparison. Kdlip 
class at the time ofadmission would have aiven a fairly aood idea of 
long-term effects of intravenous streptokinase and placebo on left 
ventricular ejection fraction. it would have bees useful to ~omparc 
patier& in Kilfip class I in the slreptokirtase group with pients in 
Killfp class I in the placebo group. 1 believe that until these issues 
are sorted, thccoacluaions drawn from this study are far from real. 
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Peel, Bombay &I9 012. kdia group had no baseline(day 3)ejectionfraction. Such absence of data 
could have been related to the prognosis of the patient and may be 
responsible for viliating the results and possibly biasing the esti- 
mated subamuo effects 16). 
Same ~herLh,unae in.the analysis ofihe data presented by the 
authors are striking. They have failed 10 mention the percent 
difference in ejection fraction they were looking for and with what 
degree of confidence. Ii is possible that the negative result obtained 
in patients with inferior wall myocardial infarction might be more 
apparent than real because of an inadequate number of patienls 
studied. II is mattdarory that Ihe authors mention the power of the 
study or beta error for that subgroup analysis when they indulge in 
such retrospective exercise. Because the I.S.A.M. trial was de- 
signed for a different purpose. sample size might have been adequate 
for studying overall differences in monalily with acceptable alpha 
and beta errors. But when the size of Ihe subgroup becomes small, 
as has happened in me preseor study, it will be wrong to presume 
that the beta error will continue to be in theacceptable range. We (7) 
have previously shown how such negative conclusions may be 
related to a low power of study while analyzing subgroups. It is well 
